The Zambia Medicines and Medical Supplies Agency ZAMMSA says it has not ditributed any defective medicines, contrary media reports that allege that defective erythromycin has been distributed to the public health facilities across the country.
ZAMMSA Senior Manager Public Relations Bradley Chingobe, says the medicine in question, which is one of the 58 products contained in the recently procured Health Centre Kits supplied by Missionpharma to ZAMMSA, has been effectively quarantined, awaiting further tests and investigations.
Mr. Chingobe said in a statement to RCV News in Lusaka today that the results from the third party-testing will determine the next course of action guided by the terms and conditions in the contract.
He affirmed to the public that the Agency is doing everything by the book and in accordance with standard operating procedures.
Meanwhile, Zambia Medicines Regulatory Authority ZAMRA Senior Public Relations Officer, Ludovic Mwape has assured the public that there is no need to be alarmed regarding the affected batches of Erythromycin Stearate as none has been distributed by ZAMMSA.
By Joanna Ndabala
